wikimedia
/
wikidata
/
Login
Register
TriplyDB
Wikidata
Browser
Triples
Insights
Schema
BETA
Class frequency
Class hierarchy
SPARQL
Graphs
1
Q50051034-20973F91-84D2-414B-8850-AD26291ADBBE
Q50051034-20973F91-84D2-414B-8850-AD26291ADBBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50051034-20973F91-84D2-414B-8850-AD26291ADBBE
Improving immune-vascular crosstalk for cancer immunotherapy.
P2860
Q50051034-20973F91-84D2-414B-8850-AD26291ADBBE
BestRank
Statement
http://www.wikidata.org/entity/statement/Q50051034-20973F91-84D2-414B-8850-AD26291ADBBE
rank
NormalRank
type
BestRank
Statement
wasDerivedFrom
6d7d24efd739d5d740e564147c9a41651d0b1415
P2860
Dual angiopoietin-2 and VEGFA inhibition elicits antitumor immunity that is enhanced by PD-1 checkpoint blockade.